Mood Disorder.
Sekhon S, Gupta V.
2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Resilience in patients with psychotic disorder.
Bozikas V, Parlapani E.
Psychiatriki. 2016 Jan-Mar;27(1):13-6.
Eveningness is associated with more severe depressive symptoms independently of sleep quality and fatigue level only in first-episode but not recurrent depression in major depressive disorder.
Hu S, Wang F, Huang Q, Chen Y, Lyu D, Zhou N, Wang M, Zhang M, Xu C, Mueller I, Yao G, Liu X, Zhang Q, Hong W.
Chronobiol Int. 2024 Jul;41(7):987-995. doi: 10.1080/07420528.2024.2378958. Epub 2024 Jul 15.
Association between overt aggression and anhedonia in patients with major depressive disorder during the acute phase.
Xu C, Wang F, Huang Q, Lyu D, Wu C, Cao T, Zhao J, Wang M, Zhou N, Yang W, Chen Y, Wei Z, Xie B, Hong W.
J Psychiatr Res. 2023 Sep;165:41-47. doi: 10.1016/j.jpsychires.2023.07.013. Epub 2023 Jul 11.
Therapeutic drug monitoring of atypical antipsychotic drugs.
Grundmann M, Kacirova I, Urinovska R.
Acta Pharm. 2014 Dec;64(4):387-401. doi: 10.2478/acph-2014-0036.
Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.
Kessing LV, Jensen HM, Christensen EM.
Psychopathology. 2008;41(3):141-6. doi: 10.1159/000113006. Epub 2008 Jan 11.
Clinical Quest for Associated Cognitive Impairment in Major Depressed Patients.
Suciu BD, Micluţia IV.
Psychiatr Q. 2020 Sep;91(3):749-759. doi: 10.1007/s11126-020-09733-6.
[Association of anhedonia with comorbid mental disorders, suicidality and personality traits in patients with depression].
Rukavishnikov GV, Kasyanov ED, Shishkovskaia TI, Olychik IV, Neznanov NG, Kibitov AO, Mazo GE.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11. Vyp. 2):85-91. doi: 10.17116/jnevro202312311285.
Cannabis and tobacco use in bipolar disorder: Associations with early onset, psychotic symptoms, and relapse risk (2015-2019).
Olivier L, Andreu H, de Juan O, Ochandiano I, Salmerón S, Fernández-Plaza T, Colomer L, Vieta E, Giménez-Palomo A, Pacchiarotti I.
J Affect Disord. 2025 Aug 1;382:30-38. doi: 10.1016/j.jad.2025.04.026. Epub 2025 Apr 11.
Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study.
Pallaskorpi S, Suominen K, Ketokivi M, Mantere O, Arvilommi P, Valtonen H, Leppämäki S, Isometsä E.
Bipolar Disord. 2015 Jun;17(4):363-74. doi: 10.1111/bdi.12291. Epub 2015 Mar 2.
